FDA, NCI to Collaborate Further on Cancer Research
By Zachary Brennan -
Published 26 June 2017
The US Food and Drug Administration (FDA) and National Cancer Institute (NCI) on Monday unveiled a memorandum of understanding (MOU) to further cooperate on understanding the molecular biology of cancer as it relates to diagnostic measurements, product development and treatment.
Categories: News, US, CDRH, Combination products, Drugs, Government affairs, In vitro diagnostics, Medical Devices
Tags: National Cancer Institute, proteogenomics, cancer research
NCI Launches Formulary to Speed Availability of Investigational Cancer Drugs
By Michael Mezher -
Published 11 January 2017
The National Cancer Institute (NCI) on Wednesday launched a new effort under the cancer "Moonshot" initiative to speed access to approved and investigational drugs for use in preclinical and clinical cancer studies.
Categories: News, US, Biologics and biotechnology, Clinical, Drugs, Preclinical
Tags: National Cancer Institute, NCI, NCI Formulary, Oncology